| Identification | |
| Name: | Crizotinib |
| Synonyms: | PF-02341066;[3-[[(R)-1-(2,6-Dichloro-3-fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine;2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-; |
| CAS: | 877399-52-5 |
| Molecular Formula: | C21H22Cl2FN5O |
| Molecular Weight: | 450.34 |
| InChI: | InChI=1/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1 |
| Molecular Structure: | ![(C21H22Cl2FN5O) PF-02341066;[3-[[(R)-1-(2,6-Dichloro-3-fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl...](https://img1.guidechem.com/chem/e/dict/0/877399-52-5.jpg) |
| Properties | |
| Density: | 1.475g/cm3 |
| Refractive index: | 1.673 |
| Safety Data | |
 |
|
